Targeting the NF-κB Pathway Enhances Responsiveness of Mammary Tumors to JAK Inhibitors

Researchers demonstrated that exposure of macrophages to janus kinase (JAK) inhibitors led to activation of NF-κB signaling, which resulted in increased expression of genes known to be associated with therapeutic resistance.